Primary invasive carcinoma associated with penoscrotal extramammary P aget's disease: a clinicopathological analysis of 56 cases
Authors:
- 17 October 2014
- journal article
- Published by Wiley in BJU International
- Vol. 115 (1) , 153-160
Abstract
Objectives: To investigate the clinicopathological features, therapeutic strategies, and prognostic factors of patients with penoscrotal invasive extramammary P aget's disease ( EMPD ). Patients and Methods: We retrospectively collected clinical, pathological, and follow‐up data of 56 men with invasive penoscrotal EMPD . Histopathological features of the primary skin lesion including tumour size, surgical margin status, depth of invasion and lymphovascular invasion were examined. Results: The median age was 67 years and median longest diameter of lesion was 5 cm. All patients were treated with wide surgical excision and 22 patients with clinically positive regional lymph nodes underwent therapeutic regional lymph node dissection. At the end of the study, 44.6% of patients developed distant metastasis and 39.3% of patients had died from disease. Univariate analysis showed that patients with one of the following poor prognostic factors: depth of invasion of lower dermis or deeper, presence of lymphovascular invasion and regional lymph node metastasis at diagnosis, had significantly shorter cancer‐specific survival time. Multivariate analysis found that depth of invasion was the only independent prognostic factor. Conclusion: The prognosis of invasive EMPD is significantly associated with depth of invasion, lymphovascular invasion and regional lymph node status. More aggressive therapy and more rigorous follow‐up should be recommended for patients with these poor prognostic factors.Keywords
Funding Information
- Guide Project of Science and Technology Commission of Shanghai Municipality (124119a7300)
- Shanghai natural science (12ZR1406600)
This publication has 27 references indexed in Scilit:
- Primary extramammary Paget's disease of the vulva: The clinicopathological features and treatment outcomes in a series of 43 patientsGynecologic Oncology, 2013
- Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget diseaseBritish Journal of Dermatology, 2013
- Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's diseaseGynecologic Oncology, 2012
- Clinicopathological study of invasive extramammary Paget’s disease: subgroup comparison according to invasion depthJournal of the European Academy of Dermatology and Venereology, 2012
- Penoscrotal Extramammary Paget's Disease: The University of Texas M. D. Anderson Cancer Center Contemporary ExperienceJournal of Urology, 2011
- Extramammary Paget’s Disease: Summary of Current KnowledgeDermatologic Clinics, 2010
- Epidemiology and treatment of extramammary Paget disease in the NetherlandsEuropean Journal of Surgical Oncology, 2007
- LYMPHOVASCULAR AND MARGINAL INVASION AS USEFUL PROGNOSTIC INDICATORS AND THE ROLE OF c-erbB-2 IN PATIENTS WITH MALE EXTRAMAMMARY PAGET'S DISEASE: A STUDY OF 31 PATIENTSJournal of Urology, 2005
- Extramammary Paget's diseaseBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Penoscrotal Extramammary Paget???s Disease: A Review of 33 Cases in a 20-Year ExperiencePlastic and Reconstructive Surgery, 2003